A Prospective Evaluation of the Peri-operative Hypoxia in Breast Cancer
Launched by TATA MEMORIAL HOSPITAL · Jan 4, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to study the effects of low oxygen levels (acute hypoxia) that can occur during surgery in women with breast cancer. Researchers want to understand how this condition might impact the tumor by collecting samples of the tumor during surgery. These samples will be analyzed later to learn more about the cancer at a genetic and protein level.
To participate in this study, women aged 65 to 74 who have been diagnosed with breast cancer and are planning to have surgery may be eligible. However, participants should not have received any chemotherapy or other cancer treatments before the surgery. If you choose to join the trial, you will need to provide consent, and you can expect to have a small part of your tumor collected during your surgery for further study. This research aims to improve our understanding of breast cancer and may help develop better treatments in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Clinically diagnosis of breast cancer (by FNAC or Biopsy)
- • 2. Not received any chemotherapy or surgical intervention except core biopsy.
- • 3. Planed for Breast cancer surgery
- • 4. Willing to give consent for the study
- Exclusion Criteria:
- • 1. Clinically diagnosis of Metastatic breast cancer
- • 2. Received any anticancer therapy
About Tata Memorial Hospital
Tata Memorial Hospital (TMH) is a premier cancer treatment and research institution located in Mumbai, India, dedicated to providing comprehensive cancer care, conducting advanced research, and offering education in oncology. Established in 1941, TMH is recognized for its commitment to improving cancer treatment outcomes through innovative clinical trials and translational research. The hospital plays a pivotal role in the development of new therapies and treatment protocols, collaborating with national and international research organizations to enhance the understanding of cancer biology and improve patient care. With a multidisciplinary team of experts, TMH strives to foster a compassionate environment that prioritizes patient welfare while advancing scientific knowledge in the field of oncology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mumbai, Maharashtra, India
Patients applied
Trial Officials
Rajendra Badwe
Principal Investigator
Director, tata Memorial Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials